Jnana has discovered a new way to potentially treat the metabolic disease PKU in its Boston labs. (Credit: Jnana)

January 30, 2024 07:00 AM EST

Exclusive: Jnana says pivotal trial of PKU pill could begin next year after promising results from a smaller study

Jnana Therapeutics, a Boston startup that’s looking to tackle a rare metabolic disease, has reported promising results from an ongoing early

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Ex­clu­sive: Jnana says piv­otal tri­al of PKU pill could be­gin next year af­ter promis­ing re­sults from a small­er study